Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ronald C. Renaud Jr currently holds 17,096 shares of KERYX BIOPHARMACEUTICALS INC (KERX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald C. Renaud Jr has been a net seller of KERX stock. They have purchased $2.1M and sold $36.3M worth of shares.
Ronald C. Renaud Jr's most recent insider trade was on Oct 10, 2024, when they sold 17,096 shares at $0.00 per share.
Ronald C. Renaud Jr serves as Executive at KERYX BIOPHARMACEUTICALS INC (KERX). They have executed 29 insider transactions totaling $38.3M over their tenure at the company.
Ronald C. Renaud Jr holds the position of Executive at KERYX BIOPHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Ronald C. Renaud Jr has shown a selling trading pattern, with $2.1M in total purchases and $36.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ronald C. Renaud Jr was on Sep 14, 2021, when they sold $19.1M worth of TBIO shares. This transaction involved 503,231 shares at $38.00 per share.
Ronald C. Renaud Jr currently owns 17,096 shares of KERYX BIOPHARMACEUTICALS INC (KERX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ronald C. Renaud Jr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ronald C. Renaud Jr has 29 Form 4 filings on record as an insider at KERYX BIOPHARMACEUTICALS INC.
Set alerts for Ronald C. Renaud Jr and 40,000+ other insiders.